NCT01708174 A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) Status COMPLETED Phase PHASE2
NCT01619865 Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01614132 Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults Status COMPLETED Phase PHASE1/PHASE2
NCT01483820 Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT01445288 Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors Status COMPLETED Phase N/A
NCT01351870 Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma (PNET4) Status COMPLETED Phase PHASE3
NCT01326104 Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Status COMPLETED Phase PHASE2
NCT01171469 Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor Status COMPLETED Phase PHASE1
NCT01125800 A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB Status COMPLETED Phase PHASE1/PHASE2
NCT00994071 A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors Status COMPLETED Phase PHASE1
NCT00983398 Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT00880308 Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00867568 TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma Status COMPLETED Phase PHASE1
NCT00867178 Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Status COMPLETED Phase PHASE1
NCT00840047 Methionine PET/CT Studies In Patients With Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00601003 Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma Status COMPLETED Phase PHASE2